In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Non-Hispanic Black patients with breast cancer undergoing neoadjuvant chemotherapy have a lower likelihood of experiencing pathologic complete response compared with non-Hispanic White patients. A new study examines several potential reasons why.

Figure 1 from The survival benefit of neoadjuvant chemotherapy and

In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

In TNBC, Pathologic Complete Response May Vary by Race/Ethnicity

Pathologic complete response and overall survival in breast cancer

Increased Activity of Two Molecular Networks Could Explain Racial

Therapeutic Options for HER2-Positive, Early-Stage Breast Cancer

In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Outcomes in breast cancer—does ethnicity matter? - ScienceDirect

The impact of race and age on response to neoadjuvant therapy and

Breast Cancer Study: African Americans Not Experiencing Complete

Cancers, Free Full-Text

Think Globally, Start Locally: Value-Based Breast Cancer Care for

The Role of Postmastectomy Radiotherapy in Locally Advanced Breast

Racial disparities in survival outcomes among breast cancer